Clinical Trials
3
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension
Phase 1
Completed
- Conditions
- Glaucoma and Ocular Hypertension
- Interventions
- Drug: Vehicle
- First Posted Date
- 2012-09-19
- Last Posted Date
- 2012-12-25
- Lead Sponsor
- Eye Therapies, LLC
- Target Recruit Count
- 15
- Registration Number
- NCT01687426
- Locations
- 🇺🇸
Clinical Site, Winchester, Massachusetts, United States
Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects
- First Posted Date
- 2012-08-30
- Last Posted Date
- 2014-07-31
- Lead Sponsor
- Eye Therapies, LLC
- Target Recruit Count
- 57
- Registration Number
- NCT01675609
- Locations
- 🇺🇸
Ora, Inc., Andover, Massachusetts, United States
A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)
Phase 2
Completed
- Conditions
- Allergic Conjunctivitis
- Interventions
- First Posted Date
- 2011-01-12
- Last Posted Date
- 2012-03-06
- Lead Sponsor
- Eye Therapies, LLC
- Target Recruit Count
- 68
- Registration Number
- NCT01275105
- Locations
- 🇺🇸
Ora, Inc., Andover, Massachusetts, United States
News
Federal Circuit Reverses Patent Board Ruling on Eye Redness Treatment, Strengthens Brimonidine Patent Protection
The Federal Circuit reversed the Patent Trial and Appeal Board's obviousness ruling that invalidated Eye Therapies' patent claims for brimonidine-based eye redness treatments.